Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NMDA receptor is a ligand-gated ion channel in the central nervous system that requires the binding of glutamate and glycine (or d-serine) for activation. The glycine binding site is located on the GluN1 subunit. Activation leads to an influx of Na+, K+, and Ca2+ ions through the channel pore. Fluctuations in extracellular levels of either glutamate or glycine/d-serine can strongly influence NMDA receptor activity, impacting normal brain function and pathological conditions such as neurodegeneration or psychiatric disorders.
Agonist/antagonist binding to the glycine site modulates NMDA receptor activity, influencing ion channel gating and downstream signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate receptor (NMDA receptor) Glycine Site (None).